Latest filing published 22 Aug 2017 for InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,), €2,029.
This profile gathers the share dealings of William James Garner in InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,). The record holds 6 filings, for trades running from 13 June 2016 to 22 August 2017.
The open-market side counts 1 purchase for €17k alongside 3 sales for €30k. On balance, insiders were net sellers of €12k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 1 option exercise. 2017 to date brings no purchases and 3 sales.
The newest entry dates from 22 August 2017: an open-market sale of €2,029, in InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,). The most recent open-market purchase was published on 14 September 2016, 3,693 days ago. Publication is fast: at least half of the trades appear on SEDI on the same day. This delay matters because a trade only becomes useful information once it is public. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations